rs34616731

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000555220.5(ZBTB25):​c.174-12931A>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.178 in 152,184 control chromosomes in the GnomAD database, including 2,548 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.18 ( 2548 hom., cov: 31)
Exomes 𝑓: 0.0 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

ZBTB25
ENST00000555220.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.183

Publications

6 publications found
Variant links:
Genes affected
ZBTB25 (HGNC:13112): (zinc finger and BTB domain containing 25) Predicted to enable DNA-binding transcription repressor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Located in nucleoplasm. [provided by Alliance of Genome Resources, Apr 2022]
MTHFD1 (HGNC:7432): (methylenetetrahydrofolate dehydrogenase, cyclohydrolase and formyltetrahydrofolate synthetase 1) This gene encodes a protein that possesses three distinct enzymatic activities, 5,10-methylenetetrahydrofolate dehydrogenase, 5,10-methenyltetrahydrofolate cyclohydrolase and 10-formyltetrahydrofolate synthetase. Each of these activities catalyzes one of three sequential reactions in the interconversion of 1-carbon derivatives of tetrahydrofolate, which are substrates for methionine, thymidylate, and de novo purine syntheses. The trifunctional enzymatic activities are conferred by two major domains, an aminoterminal portion containing the dehydrogenase and cyclohydrolase activities and a larger synthetase domain. [provided by RefSeq, Jul 2008]
MTHFD1 Gene-Disease associations (from GenCC):
  • combined immunodeficiency and megaloblastic anemia with or without hyperhomocysteinemia
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.52).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.184 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ZBTB25NM_001304508.1 linkc.174-12931A>T intron_variant Intron 2 of 2 NP_001291437.1 G3V2K3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ZBTB25ENST00000555220.5 linkc.174-12931A>T intron_variant Intron 2 of 2 1 ENSP00000450718.1 G3V2K3
MTHFD1ENST00000545908.6 linkc.*2634T>A 3_prime_UTR_variant Exon 27 of 27 2 ENSP00000438588.2 F5H2F4
ZBTB25ENST00000555424.1 linkc.257-12931A>T intron_variant Intron 2 of 2 5 ENSP00000451046.1 G3V351

Frequencies

GnomAD3 genomes
AF:
0.178
AC:
27045
AN:
152064
Hom.:
2540
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.186
Gnomad AMI
AF:
0.121
Gnomad AMR
AF:
0.185
Gnomad ASJ
AF:
0.244
Gnomad EAS
AF:
0.122
Gnomad SAS
AF:
0.167
Gnomad FIN
AF:
0.0873
Gnomad MID
AF:
0.274
Gnomad NFE
AF:
0.186
Gnomad OTH
AF:
0.209
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AF:
0.00
AC:
0
AN:
14
Hom.:
0
Cov.:
0
AF XY:
0.00
AC XY:
0
AN XY:
10
African (AFR)
AF:
0.00
AC:
0
AN:
2
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AC:
0
AN:
0
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
10
Other (OTH)
AF:
0.00
AC:
0
AN:
2
GnomAD4 genome
AF:
0.178
AC:
27079
AN:
152184
Hom.:
2548
Cov.:
31
AF XY:
0.173
AC XY:
12861
AN XY:
74408
show subpopulations
African (AFR)
AF:
0.186
AC:
7720
AN:
41496
American (AMR)
AF:
0.186
AC:
2839
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.244
AC:
847
AN:
3468
East Asian (EAS)
AF:
0.123
AC:
635
AN:
5178
South Asian (SAS)
AF:
0.168
AC:
807
AN:
4816
European-Finnish (FIN)
AF:
0.0873
AC:
926
AN:
10604
Middle Eastern (MID)
AF:
0.272
AC:
80
AN:
294
European-Non Finnish (NFE)
AF:
0.186
AC:
12677
AN:
68002
Other (OTH)
AF:
0.207
AC:
438
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1137
2273
3410
4546
5683
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
298
596
894
1192
1490
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.179
Hom.:
320
Bravo
AF:
0.189
Asia WGS
AF:
0.163
AC:
568
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.52
CADD
Benign
8.0
DANN
Benign
0.90
PhyloP100
0.18
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs34616731; hg19: chr14-64929287; API